Discover 1,239 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Nashville TN
Sponsor: Vandana Abramson
Sex: All
Age: 18+
Code: NCT07016399
Phase 2, Recruiting
Active & Responsive
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
for
Glioma, Astrocytoma, Grade IV, IDH1-mutant Glioma,
Location: Nashville TN, Birmingham AL, Lexington KY, Atlanta GA,
Sponsor: Nuvation Bio Inc.
Sex: All
Age: 18+
Code: NCT05303519
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
for
Pleuropulmonary Blastoma
Location: Nashville TN, Birmingham AL, Louisville KY, Atlanta GA,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT06647953
Phase 3, Recruiting
Active & Responsive
APLAUD Trial (Antibiotics vs PLacebo for Acute Uncomplicated Diverticulitis)
for
Acute Uncomplicated Diverticulitis
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center
Sex: All
Age: 18 - 70+
Code: NCT07492134
Phase 2, Recruiting
Active & Responsive
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
for
Cancer, Metastatic, Cancer, Cancer of Pancreas, Cancer of Liver,
Location: Nashville TN, Birmingham AL, Atlanta GA, Memphis TN,
Sponsor: Massive Bio, Inc.
Sex: All
Age: 0+
Code: NCT03452774
Recruiting
Active & Responsive
Randomized Controlled Trial Testing a Training Program About Section 504 of the Rehabilitation Act
for
Students With Disabilities and/or Family Members With Students With Disabilities That Have a Section 504 Plan,
Location: Nashville TN
Sponsor: Vanderbilt University
Sex: All
Age: 12+
Code: NCT07710300
Recruiting
Active & Responsive
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
for
Liver Transplant
Location: Nashville TN, Durham NC, Chicago IL, Ann Arbor MI,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18+
Code: NCT06075745
Phase 2, Recruiting
Active & Responsive
Whole Food for Families: A Pilot RCT of a Dietary Guidelines-Based Intervention to Prevent Type 2 Diabetes
for
PreDiabetes, Diet, Healthy, Nutritional and Metabolic Diseases
Location: Nashville TN
Sponsor: Vanderbilt University
Sex: All
Age: 6 - 59
Code: NCT06482944
Recruiting
Active & Responsive
A Randomized Controlled Trial Testing the Effect of the Youth Mindful Awareness Program on Negative Affect (YMAP2).
for
Prevention, Control
Location: Nashville TN, Evanston IL, Los Angeles CA
Sponsor: Vanderbilt University
Sex: All
Age: 12 - 17
Code: NCT06526052
Recruiting
Active & Responsive
Drumming Lessons' Influence on Children With Down Syndrome
for
Down Syndrome
Location: Nashville TN
Sponsor: Vanderbilt University
Sex: All
Age: 7 - 15
Code: NCT07156318
Recruiting
Active & Responsive
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
for
Cancer, PDAC - Pancreatic Ductal Adenocarcinoma,
Location: Nashville TN, St Louis MO, Durham NC, Fairfax VA,
Sponsor: Alterome Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06835569
Phase 1, Recruiting
Active & ResponsiveNew
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
for
Diabetes Mellitus, Type 2
Location: Nashville TN, Greensboro NC, Skokie IL,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07817251
Phase 3, Recruiting
Active & Responsive
Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)
for
Smoking Cessation
Location: Nashville TN, Knoxville TN, Evansville IN, Memphis TN,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT07766655
Phase 3, Recruiting
Active & Responsive
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
for
Relapsed Refractory Multiple Myeloma
Location: Nashville TN, Louisville KY, Atlanta GA, Charlotte NC,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07391657
Phase 3, Recruiting
Active & Responsive
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)